A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
Published online on March 14, 2026
Abstract
Journal of Psychopharmacology, Ahead of Print.
Background:Current treatments for obsessive–compulsive disorder (OCD), including serotonin reuptake inhibitors and cognitive-behavioral therapy, are often insufficient. Psilocybin, a 5HT2a agonist psychedelic, has shown promise for treating OCD, but ...
Background:Current treatments for obsessive–compulsive disorder (OCD), including serotonin reuptake inhibitors and cognitive-behavioral therapy, are often insufficient. Psilocybin, a 5HT2a agonist psychedelic, has shown promise for treating OCD, but ...